Tocilizumab treatment of COVID-19, Castleman’s Disease and Rheumatoid Arthritis: controlling IL-6 improves the pathology of diseases with a variety of etiologies
Tocilizumab treatment of COVID-19, Castleman’s Disease and Rheumatoid Arthritis: controlling IL-6 improves the pathology of diseases with a variety of etiologies
复制标题
托珠单抗治疗 COVID-19、卡斯尔曼病和类风湿关节炎：控制 IL-6 可改善多种病因疾病的病理
DOI：
--
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Yoshizaki K
中科院分区：
文献类型：
--
作者：
Uno K;Yoshizaki K
